U.S. Online Retail and Ecommerce Stock News

NasdaqCM:AHG
NasdaqCM:AHGHealthcare

Is Akso Health Group's (AHG) Early BCI Bet Quietly Redefining Its Long-Term Innovation Narrative?

In April 2026, Akso Health Group announced it had begun a next-generation Brain-Computer Interface research and development program, building foundational infrastructure to pursue ultra-high-resolution neural sensing, real-time AI neural decoding, and advanced interface design, with related patent applications pending. The company emphasized that it has not yet started human clinical trials, made any regulatory submissions, or generated revenue from BCI activities, underscoring the...
NYSE:ONTO
NYSE:ONTOSemiconductor

Onto Innovation (ONTO) Margin Reset From 21.3% To 10.3% Tests Bullish Growth Narratives

Onto Innovation (ONTO) has opened 2026 with Q1 revenue of US$291.9 million and basic EPS of US$0.68, setting a clear benchmark for how the rest of the year may shape up. The company has seen quarterly revenue move between US$218.2 million and US$291.9 million over the last six reported periods, while basic EPS has ranged from US$0.21 to US$1.30. This gives investors a concrete sense of how top line and per share earnings have tracked through recent cycles. With trailing 12 month net profit...
NYSE:PRGO
NYSE:PRGOPharmaceuticals

Perrigo (PRGO) Q1 Loss Of US$389.9 Million Tests Profit-Recovery Narratives

Perrigo (PRGO) opened Q1 2026 with revenue of US$969.2 million and a basic EPS loss of US$2.81, while net income excluding extra items came in at a loss of US$389.9 million. Over the past six reported quarters, revenue has ranged between US$969.2 million and US$1.14 billion and basic EPS has moved from a small profit of US$0.09 in Q3 2025 to a loss of US$10.20 in Q4 2025 and US$2.81 in the latest quarter, giving investors a wide view of how the income statement has changed across different...
NYSE:TTC
NYSE:TTCMachinery

Strong Q1 Beat And Guidance Hike Could Be A Game Changer For Toro (TTC)

The Toro Company recently reported past first-quarter fiscal 2026 results that exceeded analyst expectations and raised its full-year guidance, powered by strong professional segment performance and contributions from its Tornado Infrastructure Equipment acquisition. The company also underscored continued investment in innovation and operational excellence, suggesting its professional equipment and infrastructure offerings are becoming increasingly important within its overall business...
NasdaqGS:XRAY
NasdaqGS:XRAYMedical Equipment

Dentsply Sirona (XRAY) Narrower Q1 Loss Tests Bullish Margin Recovery Narrative

DENTSPLY SIRONA (XRAY) has opened 2026 with Q1 revenue of US$880 million and a basic EPS loss of US$0.05, alongside net income excluding extra items of a US$10 million loss, setting a cautious tone around current profitability. Over the past year, the company has seen quarterly revenue move between US$879 million and US$961 million, while basic EPS has ranged from a profit of US$0.10 to a loss of US$2.16. This underlines how volatile earnings have been even as the top line has stayed close to...
NYSE:NGVT
NYSE:NGVTChemicals

Assessing Ingevity (NGVT) Valuation After Strong Q1 2026 Earnings And Share Price Momentum

Ingevity (NGVT) has drawn fresh attention after reporting first quarter 2026 results, with sales of US$258 million and net income of US$59.8 million, compared to US$247.9 million and US$20.5 million a year earlier. See our latest analysis for Ingevity. The earnings release appears to have been a key catalyst for the recent share price move, with a 10.49% 1 month share price return and a 29.59% year to date share price return. The 1 year total shareholder return of 98.5% points to strong...
NYSE:OWL
NYSE:OWLCapital Markets

Has Blue Owl Capital (OWL) Rallied Too Far After Its Recent Share Price Surge

Wondering whether Blue Owl Capital is attractively priced today, or if the recent excitement has already been baked into the stock. The share price closed at US$10.54, with recent returns of 18.7% over 7 days and 24.7% over 30 days, set against a year to date return of negative 31.2% and a 1 year return of negative 38.3%. These swings sit against a backdrop of ongoing interest in alternative asset managers and the broader capital markets sector. In this environment, investors often reassess...
NasdaqGS:AEIS
NasdaqGS:AEISElectronic

Is It Too Late To Consider Advanced Energy Industries (AEIS) After A 229% One Year Surge?

Investors may be wondering if Advanced Energy Industries at around US$360.81 is priced for perfection or still offers value, especially after such a strong run. The stock has been relatively steady over the last 7 days with a 0.2% decline. The 30 day return of 8.7% and 1 year return of 229.3% sit alongside multi year returns of 324.7% over 3 years and 315.6% over 5 years. Recent coverage has focused on Advanced Energy Industries as investors look at how its power conversion and control...
NasdaqGS:MRX
NasdaqGS:MRXCapital Markets

Marex Group (MRX) Earnings Growth And 10.2% Margin Keep Automation Narrative In Question

Marex Group (MRX) has opened 2026 with Q1 revenue of US$1.1b and basic EPS of US$1.57, alongside trailing twelve month EPS of US$4.65 and net income of US$333.9m, putting fresh numbers in front of investors watching its recent earnings momentum. Over the past year, the company has seen revenue move from US$2.36b to US$3.27b and EPS lift from US$2.96 to US$4.65 on a trailing basis, setting a clear context for how the latest quarterly print fits into the broader trend. Taken together with the...
NYSE:CALY
NYSE:CALYLeisure

Callaway Golf’s Q1 2026 Earnings Could Be A Game Changer For Callaway Golf (CALY)

Callaway Golf Company recently confirmed it will release its Q1 2026 results and hold its earnings call on May 7, 2026, after the US market close, following a quarter in which it missed revenue expectations and lowered full-year guidance. This upcoming report has drawn attention because analysts are looking for year-on-year revenue growth after last year's decline, making it a key moment to reassess the strength of Callaway's recovery story. With analysts expecting Q1 revenue growth after...